PRIMARY Site Table – 2015
Continued Cancer Registry : Frequency by Primary Site and Gender
Summary by Body System , Sex , Class , Status and Best CS / AJCC Stage Report
Primary Site Total (%)
Other Endocrine including Thymus
Sex Class of Case Status Stage
M F Analytic NA Alive Exp Stg 0
25 ( 1.2 %) 12 13 15 10 25 0 0 0 0 0 0 15 LYMPHOMA 91 ( 4.3 %) 48 43 69 22 79 12 0 14 12 5 26 12 Hodgkin Lymphoma 10 ( 0.5 %) 6 4 9 1 10 0 0 1 4 0 2 2 Non-Hodgkin Lymphoma 81 ( 3.8 %) 42 39 60 21 69 12 0 13 8 5 24 10 NHL - Nodal 49 26 23 37 12 40 9 0 8 6 4 16 3 NHL - Extranodal 32 16 16 23 9 29 3 0 5 2 1 8 7 MYELOMA 29 ( 1.4 %) 20 9 16 13 24 5 0 0 0 0 0 16 Myeloma 29 ( 1.4 %) 20 9 16 13 24 5 0 0 0 0 0 16 LEUKEMIA 70 ( 3.3 %) 39 31 47 23 58 12 0 0 0 0 0 47
Lymphocytic Leukemia 36 ( 1.7 %) 23 13 18 18 36 0 0 0 0 0 0 18
Acute Lymphocytic Leukemia Chronic Lymphocytic Leukemia Other Lymphocytic Leukemia Myeloid & Monocytic Leukemia
6 5 1 6 0 6 0 0 0 0 0 0 6 29 17 12 11 18 29 0 0 0 0 0 0 11 1 1 0 1 0 1 0 0 0 0 0 0 1
31 ( 1.4 %) 14 17 26 5 20 11 0 0 0 0 0 26 Acute Myeloid Leukemia 17 9 8 14 3 9 8 0 0 0 0 0 14 Acute Monocytic Leukemia 1 0 1 1 0 0 1 0 0 0 0 0 1 Chronic Myeloid Leukemia 13 5 8 11 2 11 2 0 0 0 0 0 11 Other Leukemia 3 ( 0.1 %) 2 1 3 0 2 1 0 0 0 0 0 3 MESOTHELIOMA 1 ( 0.0 %) 1 0 1 0 1 0 0 1 0 0 0 0 Mesothelioma 1 ( 0.0 %) 1 0 1 0 1 0 0 1 0 0 0 0 KAPOSI SARCOMA 1 ( 0.0 %) 1 0 0 1 1 0 0 0 0 0 0 0 Kaposi Sarcoma 1 ( 0.0 %) 1 0 0 1 1 0 0 0 0 0 0 0 MISCELLANEOUS 97 ( 4.5 %) 52 45 64 33 60 37 0 0 0 0 0 64 Miscellaneous 97 ( 4.5 %) 52 45 64 33 60 37 0 0 0 0 0 64 Total 2,139 951 1,188 1,757 382 1,775 364 139 487 319 202 289 321
Stg I
Stg II
Stg III
Stg IV
No Stg
Exclusions : Not Male and Not Female 0
21